iShares MSCI Hong Kong ETF vs Xylem, Inc. — how do they compare? iShares MSCI Hong Kong ETF trades at $22.06 (market cap $1.16B), while Xylem, Inc. trades at $102.71 (market cap $23.81B). The key difference: Xylem, Inc. is far larger — about 20.5× iShares MSCI Hong Kong ETF's market cap, and Xylem, Inc. pays a 1.69% dividend while iShares MSCI Hong Kong ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Hong Kong ETF for 61 Days and Xylem, Inc. for 50 Days on average.
| EWH | XYL | |
|---|---|---|
Market Cap | $1.16B | $23.81B |
Volume | 3,176,523 | 2,234,713 |
Sector | Broad Market / Factor | Industrials |
52-Week High | $24.55 | $152.95 |
52-Week Low | $20.66 | $100.92 |
Typical Hold Time | 61 Days | 50 Days |
Enterprise Value | — | $25.59B |
Dividend Yield | — | 1.69% |
Signals from Pluang's Aura AI — not financial advice
EWH, the iShares MSCI Hong Kong ETF, trades at $21.72 with a slight 0.65% daily gain amid a predominantly bearish technical backdrop. The ETF's underlying index, the Hang Seng, has faced significant pressure, dropping over 11% from yearly highs due to Federal Reserve policy concerns and US-Iran geopolitical tensions. Technical indicators show bearish moving averages but neutral oscillators, with RSI levels suggesting potential oversold conditions. Recent institutional activity includes Empowered Funds reducing its position by 70.2% in August 2026.
The outlook remains challenged by Hong Kong's market volatility and external pressures, though current levels may attract contrarian interest given the substantial decline from peaks. Key risks include ongoing geopolitical friction, Federal Reserve policy impacts, and China's economic struggles. Upside potential depends on stabilization in Chinese technology stocks and resolution of international tensions.
Xylem (XYL) trades at $101.99, up 0.16% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.46 surpassing the $1.35 estimate. Revenue grew to $9.04B in 2025, and net income margin improved to 10.59%. Recent developments include a $1.5B senior note offering to fund acquisitions and the appointment of a new CFO.
The outlook is supported by solid fundamentals and analyst optimism, with a consensus price target of $149.13 implying significant upside. However, risks include China market weakness and higher debt from recent acquisitions. The stock offers a dividend yield with a $0.43 per share payout declared for Q3 2026.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
EWH tracks the MSCI Hong Kong 25/50 Index, providing broad exposure to large and mid-cap companies listed in Hong Kong. It focuses on the established pillars of the local economy, with heavy weightings in financials, real estate, and utilities, serving as a single-country diversification tool.
Read more on EWH →Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →